EarningsQ1 2026 Earnings Report

BioMarin Pharmaceutical (BMRN) Q1 2026 Earnings Report

0 Followers

MX:BMRN Q1 2026 EPS Results

Actual EPS$13.87

Consensus EPS$12.63

Beat/MissBeat by +$1.24

One Year Ago EPS$17.34

Actual Revenue$14.21B

Expected Revenue$13.74B

Beat/MissBeat by +$476.21M

YoY Revenue Growth+6.28%

QuarterQ1 2026

Date05/04/2026

TimeAfter Close

Conference CallMonday, May 4, 2026

MX:BMRN Upcoming Earnings

BioMarin Pharmaceutical's next earnings date is estimated for November 3, 2026, based on past reporting schedules.

MX:BMRN Q1 2026 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 03, 2026	2026 (Q3)	24.55 / -	-2.921	―
Aug 06, 2026	2026 (Q2)	17.29 / 21.91	22.453	-2.44% (-0.55)
May 04, 2026	2026 (Q1)	12.63 / 13.87	17.342	-20.00% (-3.47)
Feb 23, 2026	2025 (Q4)	3.09 / -4.38	11.683	-137.50% (-16.06)
Oct 27, 2025	2025 (Q3)	-5.11 / -2.92	10.04	-129.09% (-12.96)
Aug 04, 2025	2025 (Q2)	15.72 / 22.45	10.04	123.64% (+12.41)
May 01, 2025	2025 (Q1)	13.03 / 17.34	8.397	106.52% (+8.94)
Feb 19, 2025	2024 (Q4)	9.75 / 11.68	2.008	481.82% (+9.67)
Oct 29, 2024	2024 (Q3)	9.69 / 10.04	3.833	161.90% (+6.21)
Aug 05, 2024	2024 (Q2)	6.54 / 10.04	5.294	89.66% (+4.75)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed